{"id":2585,"date":"2024-03-28T21:07:18","date_gmt":"2024-03-28T21:07:18","guid":{"rendered":"https:\/\/healthynewsusa.com\/?p=2585"},"modified":"2024-03-28T21:07:19","modified_gmt":"2024-03-28T21:07:19","slug":"the-supreme-court-and-the-abortion-pill","status":"publish","type":"post","link":"https:\/\/healthynewsusa.com\/?p=2585","title":{"rendered":"The Supreme Court and the Abortion Pill"},"content":{"rendered":"
\n
\n

\n\t\tThe Host\t<\/h3>\n
\n
\n
\n\t\t\t\n\t\t<\/div>\n<\/div><\/div>\n<\/div>\n

In its first abortion case since the overturning of Roe v. Wade<\/em> in 2022, the Supreme Court this week looked unlikely to uphold an appeals court ruling that would dramatically restrict the availability of the abortion pill mifepristone. But the court already has another abortion-related case teed up for April, and abortion opponents have several more challenges in mind to limit the procedure in states where it remains legal.<\/p>\n

Meanwhile, Republicans, including former President Donald Trump, continue to take aim at popular health programs like Medicare, Medicaid, and the Affordable Care Act on the campaign trail \u2014 much to the delight of Democrats, who feel they have an advantage on the issue.<\/p>\n

This week\u2019s panelists are Julie Rovner of KFF Health News, Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Lauren Weber of The Washington Post.<\/p>\n

Among the takeaways from this week\u2019s episode:<\/p>\n